Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
holding | ASO | Common Stock | 6.34K | Jun 25, 2023 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
holding | ASO | Stock Options (Right to Buy) | Jun 25, 2023 | Common Stock | 11.4K | $26.99 | Direct | F1, F2 | ||||||
holding | ASO | Stock Options (Right to Buy) | Jun 25, 2023 | Common Stock | 10.2K | $39.17 | Direct | F1, F3 | ||||||
holding | ASO | Restricted Stock Units | Jun 25, 2023 | Common Stock | 1.22K | Direct | F1, F4, F5 | |||||||
holding | ASO | Restricted Stock Units | Jun 25, 2023 | Common Stock | 1.63K | Direct | F1, F5, F6 | |||||||
holding | ASO | Restricted Stock Units | Jun 25, 2023 | Common Stock | 7.45K | Direct | F1, F5, F7 | |||||||
holding | ASO | Restricted Stock Units | Jun 25, 2023 | Common Stock | 3.87K | Direct | F1, F5, F8 |
Id | Content |
---|---|
F1 | Granted under the Company's 2020 Omnibus Incentive Plan (the "Plan"). |
F2 | These time-based stock options vest in four annual installments beginning on March 31, 2022. |
F3 | These time-based stock options vest in four annual installments beginning on March 30, 2023. |
F4 | On March 31, 2021, the Reporting Person was granted 2,445 performance-based restricted stock units. These performance-based restricted stock units vest if certain performance criteria and/or Issuer stock price conditions are met and certified by the Issuer's compensation committee. Following certification of achievement of the performance criteria during fiscal 2021 by the Issuer's compensation committee on March 2, 2022, 25% of this grant vested on March 2, 2022, and the remaining 75% vest in three equal annual installments beginning on January 31, 2023. |
F5 | Each restricted stock unit represents a contingent right to receive one share of Issuer common stock, par value $0.01 per share ("Common Stock"). |
F6 | On March 30, 2022, the Reporting Person was granted 2,125 performance-based restricted stock units ("RSUs"). These RSUs vest if certain performance criteria and/or Issuer stock price conditions are met and certified by the Issuer's compensation committee. On March 1, 2023, the Issuer's compensation committee certified achievement of 93.7% of the performance criteria during fiscal 2022 meaning that 1,990 RSUs were deemed earned. Of this earned amount, 25% of the earned amount of this grant vested on March 1, 2023, and the remaining 75% will vest in three equal annual installments beginning on January 30, 2024, subject to the Reporting Person's continued service with the Issuer through each applicable vesting date. The remaining unearned amount of this grant (i.e., 135 RSUs) may vest upon certification by the Issuer's compensation committee of achievement of certain Issuer stock price conditions as of the fourth anniversary of the Vesting Commencement Date (i.e., January 30, 2022). |
F7 | On April 15, 2022, the Reporting Person was granted 7,449 time-based restricted stock units that vest 50% on each the second and third anniversary of the grant date. |
F8 | On March 21, 2023, the Reporting Person was granted 3,865 time-based restricted stock units that vest in three equal installments beginning on the first anniversary of the grant date. |
This Form 3 amendment is being filed solely to correct the original Form 3 filed on June 26, 2023, to include the Reporting Person's Power of Attorney. EXHIBIT LIST: EX-24: Power of Attorney Matthew M. McCabe